1. let’s say paracetamol didn’t exist and aspirin was just getting developed.
2. let’s say inflammation is a root cause of lots and lots of conditions in the body.
3. let’s say that aspirin's mechanism of action is to reduce inflammation.
4. let's say the first clinical trial showed aspirin helped relieve migraine headache and even prevented migraine from developing once it showed signs of starting. it then got approved as a migraine treatment drug and the insurance companies agreed to pay big bucks as a migraine treatment drug to the big pharma company that owned it.
5. let's say that aspirin was then shown to reduce inflammation and associated pain in influenza and osteoarthritis and neuralgia and depression and heart disease and tension headache and post-operation pain, and so on for hundreds of inflammation and pain conditions.
Question: does the big pharma owner of this panacea-type treatment drug get a big reimbursement from insurance companies for all the approved indications, and as a result, this lucky big pharma ends up taking over the whole world because of its humongous windfall profits? Or does something else happen?
NEU Price at posting:
$23.33 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)